ILD
Promising results for treprostinil in pulmonary hypertension associated with ILD
Inhaled treprostinil shows some promise as a treatment for pulmonary hypertension associated with ILD, according to US research. The study randomised 326 patients to treprostinil (0.6 mg per ml) or placebo delivered by a nebuliser four times daily for 16 weeks....
Inhaled treprostinil shows some promise as a treatment for pulmonary hypertension associated with ILD, according to US research. The study randomised...
Read more


